Despite advances in the management of and changes in clinical practice, little is known about the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies patients in France. In order to better understand the characteristics of rare peritoneal surface malignancies and to evaluate treatment strategies, the RENAPE registry aims at the collection of data from patients presenting with a rare peritoneal surface malignancy in France. Data will be entered prospectively in a specifically designed and secured web database. All RENAPE's centres and physicians are invited to register patients with a rare peritoneal surface malignancy diagnosis and to participate to the registry. Data will be evaluated within regular time frames, focusing on types of rare peritoneal surface malignancies, treatment modalities and patient outcomes (e.g. survival, recurrence), thereby contributing to the better understanding of these rare cancers.
Study Type
OBSERVATIONAL
Enrollment
2,171
Data collection
Institut de Cancérologie de l'Ouest - Paul Papin
Angers, France
CHU Jean Minjoz
Besançon, France
Institut Bergonié
Bordeaux, France
Centre François Baclesse
Caen, France
CHU Estaing
Clermont-Ferrand, France
Centre Jean Perrin
Clermont-Ferrand, France
Incidence of rare peritoneal surface malignancies
Collect detailed clinical and histological diagnosis for estimating annual incidence rate
Time frame: year 5
Impact of specific treatment strategies
Collect detailed therapeutic strategies (surgical procedure, chemotherapy, etc.) on patients with rare peritoneal surface malignancies
Time frame: year 5
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
AP-HP Louis MOURIER
Colombes, France
CHU Bocage
Dijon, France
CHU A. Michallon
La Tronche, France
Centre Oscar Lambret
Lille, France
...and 23 more locations